Therapeutic Goods Regulations (Amendment) 1996 No. 200
EXPLANATORY STATEMENT
STATUTORY RULES 1996 No. 200
Therapeutic Goods Act 1989
Therapeutic Goods Regulations (Amendment)
The Therapeutic Goods Act 1989 ("the Act") has for its objective the establishment and maintenance of a national system of controls relating to the quality, safety, efficacy and timely availability of therapeutic goods that are used in Australia or exported from Australia. The application of the Act is limited by the Federal Constitution so that it cannot extend to regulate, for example, individuals who manufacture and supply therapeutic goods within a State or Territory. To achieve uniformity of regulation in respect of the manufacture and supply of therapeutic goods throughout Australia, State and Territory legislation to complement the Act will be required.
Through the Australian Health Ministers' Advisory Council. State and Territory governments have agreed with the Commonwealth that they will introduce "complementary legislation" to cover individuals and activities that cannot be covered by the Act under a truly national scheme of legislative controls. The State of New South Wales enacted its complementary legislation on 1 September 1996, and the Poisons and Therapeutic Goods Act 1966 is to commence from that day. Under the arrangements agreed between the Commonwealth and the States and Territories, the Commonwealth is to be delegated the relevant powers and functions under State/Territory legislation. Before this can occur, such State enactments must first be declared to be a "corresponding State law" under the Therapeutic Goods Regulations for the purposes of section 6A of the Act.
Section 63 of the Act enables the Governor General to make regulations prescribing, among other things, matters necessary or convenient to be prescribed for carrying out or giving effect to the Act. Subsection 3(1) of the Act provides that regulations may be made to declare a State law that corresponds with the Act to be a "corresponding State law" for the purposes of enabling State functions and powers under such laws to be delegated to the Secretary in accordance with section 6A of the Act.
Accordingly, the amending Regulations declared the Poisons and Therapeutic Goods Act 1966 and the Poisons and Therapeutic Goods Regulation 1994 to be "corresponding State law".
The Regulations commence upon Gazettal.
Overview
The Therapeutic Goods Act 1989 was enacted to establish and maintain a national system of controls ensuring the quality, safety, efficacy, and timely availability of therapeutic goods used or exported from Australia. However, due to constitutional limitations, the Act does not cover all aspects of therapeutic goods regulation within the states and territories. To address this gap, the Therapeutic Goods Regulations (Amendment) 1996 were introduced to declare certain state legislation as "corresponding State laws" under the Act. This allows for the delegation of relevant powers and functions to the Commonwealth, facilitating a unified national scheme. Specifically, these amending regulations declared the Poisons and Therapeutic Goods Act 1966 of New South Wales, along with associated regulations, as corresponding State laws. This legislative amendment aims to achieve uniformity in the regulation of therapeutic goods across Australia.
Scope and Application
The Therapeutic Goods Act 1989 (the Act) is designed to establish and maintain a national system of controls concerning the quality, safety, efficacy, and timely availability of therapeutic goods both for use within Australia and for export. This Act applies to the regulation of therapeutic goods, ensuring they meet stringent standards before being made available to the public. However, due to the constraints imposed by the Federal Constitution, the Act's jurisdiction is limited to matters of national concern, and it does not extend to regulating individuals who manufacture and supply therapeutic goods purely within a state or territory. To address this, complementary legislation will be introduced by state and territory governments to cover activities not governed by the federal Act, thereby ensuring a unified regulatory framework across the nation. The Therapeutic Goods Regulations (Amendment) 1996 further this objective by declaring certain state laws as "corresponding State law," facilitating the delegation of state functions and powers to the Secretary, thereby integrating state and federal regulatory efforts. The amending Regulations specifically declared the Poisons and Therapeutic Goods Act 1966 and the Poisons and Therapeutic Goods Regulation 1994 as "corresponding State law," which aids in the creation of a cohesive national scheme of legislative controls over therapeutic goods.
Key Provisions
The Therapeutic Goods Regulations (Amendment) 1996 No. 200 primarily serves to amend the Therapeutic Goods Regulations under the Therapeutic Goods Act 1989. It includes the declaration of certain state laws as "corresponding State laws" (section 63(3)(1)), which facilitates the delegation of state functions and powers under these laws to the Secretary of the Commonwealth. Specifically, this amendment recognises the Poisons and Therapeutic Goods Act 1966 of New South Wales, along with its corresponding regulations, as laws that align with the federal objectives of the Therapeutic Goods Act 1989.
The obligations imposed by these regulations on parties and entities revolve around ensuring that any therapeutic goods manufactured or supplied within Australia, or exported from Australia, adhere to the national standards set by the Therapeutic Goods Act 1989. Manufacturers, suppliers, and other relevant entities must comply with the quality, safety, efficacy, and timely availability requirements of therapeutic goods. These regulations also mandate that state laws, when declared as "corresponding State laws," must align with the federal objectives and be capable of being delegated to the Commonwealth for administration.
Breaching the provisions of the Therapeutic Goods Act 1989 or the Therapeutic Goods Regulations can lead to significant legal consequences. Under the Act, offences may include the manufacture, supply, or distribution of therapeutic goods that do not meet the required standards. The penalties for such breaches can vary widely, depending on the severity of the offence. For example, supplying goods that do not comply with the Act may result in fines or imprisonment. The maximum penalties for certain offences can extend to substantial financial penalties and/or imprisonment terms, as stipulated under the Act. Civil liabilities may also apply, where affected parties can seek damages for any harm caused by non-compliant therapeutic goods.